Grantham, Mayo, Van Otterloo & Co (GMO)’s NetEase NTES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,700
Closed -$372K 697
2025
Q4
$372K Sell
2,700
-12,700
-82% -$1.8M ﹤0.01% 602
2025
Q3
$2.34M Buy
+15,400
New +$2.12M 0.01% 361
2024
Q2
Sell
-46,179
Closed -$4.78M 567
2024
Q1
$4.78M Buy
+46,179
New +$4.72M 0.02% 310
2023
Q1
Sell
-140,396
Closed -$10.2M 749
2022
Q4
$10.2M Sell
140,396
-293,275
-68% -$20M 0.05% 229
2022
Q3
$32.8M Sell
433,671
-80,458
-16% -$7.08M 0.19% 105
2022
Q2
$48M Buy
+514,129
New +$48.9M 0.26% 73
2022
Q1
Sell
-18,181
Closed -$1.85M 745
2021
Q4
$1.85M Sell
18,181
-156,279
-90% -$15.9M 0.01% 475
2021
Q3
$14.9M Sell
174,460
-482,205
-73% -$45.5M 0.07% 204
2021
Q2
$75.7M Sell
656,665
-413,900
-39% -$45.6M 0.38% 57
2021
Q1
$111M Sell
1,070,565
-769,335
-42% -$87.1M 0.6% 37
2020
Q4
$176M Sell
1,839,900
-233,100
-11% -$20.9M 1.08% 28
2020
Q3
$189M Buy
2,073,000
+618,000
+42% +$58.1M 1.34% 25
2020
Q2
$125M Buy
1,455,000
+130,000
+10% +$9.79M 0.93% 28
2020
Q1
$85.1M Buy
1,325,000
+835,500
+171% +$55M 0.71% 34
2019
Q4
$30M Buy
489,500
+188,500
+63% +$11M 0.2% 86
2019
Q3
$16M Buy
301,000
+108,500
+56% +$5.52M 0.11% 130
2019
Q2
$9.85M Sell
192,500
-53,500
-22% -$2.84M 0.07% 191
2019
Q1
$11.9M Buy
246,000
+121,000
+97% +$5.75M 0.09% 159
2018
Q4
$5.88M Buy
125,000
+24,000
+24% +$1.08M 0.05% 171
2018
Q3
$4.61M Buy
101,000
+91,000
+910% +$4.19M 0.03% 211
2018
Q2
$505K Sell
10,000
-606,500
-98% -$31M ﹤0.01% 465
2018
Q1
$34.6M Buy
616,500
+247,000
+67% +$15.5M 0.21% 80
2017
Q4
$25.5M Sell
369,500
-1,252,500
-77% -$78.2M 0.15% 97
2017
Q3
$85.6M Buy
1,622,000
+1,007,500
+164% +$57.9M 0.5% 50
2017
Q2
$36.9M Buy
614,500
+383,500
+166% +$22M 0.2% 90
2017
Q1
$13.1M Buy
231,000
+150,000
+185% +$8.08M 0.07% 169
2016
Q4
$3.49M Buy
81,000
+2,500
+3% +$119K 0.02% 267
2016
Q3
$3.78M Sell
78,500
-116,000
-60% -$4.94M 0.02% 275
2016
Q2
$7.52M Buy
+194,500
New +$6.05M 0.03% 257

Other funds holding NTES

Grantham, Mayo, Van Otterloo & Co (GMO)'s NTES Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of NetEase (NTES) in Q1 2026, closing a stake of 2,700 shares — an estimated $372K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NTES in Q2 2016 and held it in 29 quarters. The position peaked at $189M in Q3 2020. 428 funds tracked by Wall St. Rank hold NTES as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining NetEase position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,700 NetEase shares in Q1 2026, an estimated $372K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NetEase in Q2 2016 and held it in 29 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s NetEase position peaked at $189M in Q3 2020.
  • 428 funds tracked by Wall St. Rank held NetEase as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.